TABLE 3.
Fatty acids that correlate with CSF Aβ42 or T-tau levels.
| CSF fraction | CH | CH-NAT | CH-PAT |
| Fatty acid levels that correlate with CSF Aβ42 | |||
| NP PUFA | C18:2n-6, (−0.3)* | C18:3n-6, (−0.34)* | |
| n-6, (−0.25)* | N-6/N-3 npPUFA, (−0.38)* | ||
| AA/DHA, (−0.37)* | |||
| AA/(EPA+DHA), (−0.35)* | |||
| Unesterified PUFA | C22:5n-3, (−0.38)* | ||
| C22:6n-3, (−37)* | |||
| n-3 uPUFA, (−0.38)* | |||
| uPUFA, (−0.37)* | |||
| AA/(EPA+DHA), (0.46)** | |||
| Fatty acid levels that correlate with CSF T-tau levels | |||
| NP PUFA | C20:4n-6, (0.38)* | ||
| SF PUFA | C20:4n-6, (0.26)* | C18:2n-6, (−0.38)* | C20:4n-6, (0.35)* |
| C22:6n-3, (0.43)*** | C22:6n-3, (0.40)* | C22:6n-3, (0.54)** | |
| n-3, (0.29)* | n-3, (0.48)** | ||
Spearman correlation coefficient (ρ) with p < 0.05 (*), p < 0.01 (**), and p < 0.005 (***).